You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-FGF9 antibody (ab71395)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-FGF9 antibody
See all FGF9 products (7) ...

Description

Rabbit polyclonal to FGF9

Tested applications

ICC/IF, IHC-P, WBmore details

Cross reactivity

Reacts with

Mouse, Human

Predicted to work with

Rat, Chicken, Pig, Xenopus laevis

Immunogen

Synthetic peptide conjugated to KLH derived from within residues 1 - 100 of Human FGF9.

(Peptide available as ab86940.)

Positive control

This antibody gave a positive signal in the following lysates: Human Brain Tissue; Human Stomach Tumour Tissue; HEK293 Whole Cell; Mouse Brain Tissue; Mouse Kidney Tissue.

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 0.02% Sodium Azide
Constituents: 1% BSA, PBS, pH 7.4

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Isotype

IgG

  • Immunocytochemistry/ Immunofluorescence - FGF9 antibody (ab71395)Immunocytochemistry/ Immunofluorescence - FGF9 antibody (ab71395) image (enlarge)

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - FGF9 antibody (ab71395)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - FGF9 antibody (ab71395) image (enlarge)

  • Western blot - FGF9 antibody (ab71395)Western blot - FGF9 antibody (ab71395) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab71395 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

May have a role in glial cell growth and differentiation during development, gliosis during repair and regeneration of brain tissue after damage, differentiation and survival of neuronal cells, and growth stimulation of glial tumors.

Tissue specificity

Glial cells.

Involvement in disease

Defects in FGF9 are the cause of multiple synostoses syndrome type 3 (SYNS3) [MIM:612961]. Multiple synostoses syndrome is an autosomal dominant condition characterized by progressive joint fusions of the fingers, wrists, ankles and cervical spine, characteristic facies and progressive conductive deafness.

Sequence similarities

Belongs to the heparin-binding growth factors family.

Post-translational
modifications

Three molecular species were found (30 kDa, 29 kDa and 25 kDa), cleaved at Leu-4, Val-13 and Ser-34 respectively. The smaller ones might be products of proteolytic digestion. Furthermore, there may be a functional signal sequence in the 30 kDa species which is uncleavable in the secretion step.
N-glycosylated.

Cellular localization

Secreted.

Target information above from: UniProt accessionP31371 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • FGF 9 antibody
  • FGF-9 antibody
  • FGF9 antibody
  • FGF9_HUMAN antibody
  • Fibroblast Growth Factor 9 antibody
  • GAF antibody
  • Glia Activating Factor antibody
  • Glia-activating factor antibody
  • HBFG 9 antibody
  • HBFG9 antibody
  • HBGF-9 antibody
  • Heparin-binding growth factor 9 antibody
  • MGC119914 antibody
  • MGC119915 antibody
see all

Anti-FGF9 antibody images:

  Immunocytochemistry/ Immunofluorescence - FGF9 antibody (ab71395)

Immunocytochemistry/ Immunofluorescence - FGF9 antibody (ab71395)

ICC/IF image of ab71395 stained MCF7 cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab71395, 5µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM. This antibody also gave a positive result in 100% methanol fixed (5 min) HeLa, hek293 and MCF7 cells at 5µg/ml.

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - FGF9 antibody (ab71395)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - FGF9 antibody (ab71395)

IHC image of FGF9 staining in FFPE human kidney carcinoma formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab71395, 1µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

  Western blot - FGF9 antibody (ab71395)

Western blot - FGF9 antibody (ab71395)

All lanes : Anti-FGF9 antibody (ab71395) at 1 µg/ml

Lane 1 : Brain (Human) Tissue Lysate - adult normal tissue (ab29466)
Lane 2 : Stomach (Human) Whole Cell Lysate - tumor tissue (ab29678)
Lane 3 : HEK293 (Human embryonic kidney cell line) Whole Cell Lysate
Lane 4 : Brain (Human) Tissue Lysate - adult normal tissue (ab29466) with FGF9 peptide (ab86940) at 1 µg/ml
Lane 5 : Stomach (Human) Whole Cell Lysate - tumor tissue (ab29678) with FGF9 peptide (ab86940) at 1 µg/ml
Lane 6 : HEK293 (Human embryonic kidney cell line) Whole Cell Lysate with FGF9 peptide (ab86940) at 1 µg/ml

Lysates/proteins at 10 µg per lane.

Secondary
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Predicted band size : 23 kDa
Observed band size : 50 kDa (why is the actual band size different from the predicted?)
Additional bands at : 100 kDa. We are unsure as to the identity of these extra bands.

The peptide blocking data above shows that ab71395 detects a protein of approximately 50 kDa, thought to be FGF9. It is possible that this band is significantly higher than expected due to modifications at potential glycosylation sites.

  Western blot - Anti-FGF9 antibody (ab71395)

Western blot - Anti-FGF9 antibody (ab71395)

All lanes : Anti-FGF9 antibody (ab71395) at 1 µg/ml

Lane 1 : Brain (Mouse) Tissue Lysate
Lane 2 : Kidney (Mouse) Tissue Lysate

Lysates/proteins at 10 µg per lane.

Secondary
Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (HRP), pre-adsorbed (ab97080) at 1/5000 dilution
developed using the ECL technique

Performed under reducing conditions.

Predicted band size : 23 kDa
Observed band size : 55 kDa (why is the actual band size different from the predicted?)
Additional bands at : 105 kDa. We are unsure as to the identity of these extra bands.

Exposure time : 2 minutes

References for Anti-FGF9 antibody (ab71395)

ab71395 has not yet been referenced specifically in any publications.

Publishing research using ab71395? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"